Eagle Pharmaceuticals to Present at Upcoming September 2020 Healthcare Conferences

Sept. 8, 2020 10:50 UTC

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at two upcoming conferences in September.

At the Morgan Stanley 18th Annual Virtual Global Healthcare Conference:


Monday, September 14, 2020


3:00 p.m. Eastern Time

Webcast: https://morganstanley.webcasts.com/starthere.jsp?ei=1362588&tp_key=91c8ad632b

At the Cantor Virtual Global Healthcare Conference:


Tuesday, September 15, 2020


10:00 a.m. Eastern Time

Webcast: https://www.webcaster4.com/Webcast/Page/2495/37184

The presentations will be webcast live at the aforementioned times, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors + News Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include RYANODEX®, BENDEKA®, BELRAPZO®, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200908005348/en/


Investor Relations for Eagle Pharmaceuticals, Inc:
Lisa M. Wilson
T: 212-452-2793
E: lwilson@insitecony.com


Source: Eagle Pharmaceuticals, Inc.

Back to news